Paper30026331
Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis.
Shabaneh TB and 9 others. Cancer Res, 2018. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis. Papers, record 30026331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30026331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinogenesis | Major topic |
| Melanoma | Major topic |
| Proto-Oncogene Proteins B-raf | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Animals | |
| Antigens, Neoplasm | |
| CD8-Positive T-Lymphocytes | |
| Cell Line, Tumor | |
| Disease Models, Animal | |
| Gene Expression Regulation, Neoplastic | |
| Humans | |
| Lymph Nodes | |
| Melanocytes | |
| Mice | |
| Mutation | |
| PTEN Phosphohydrolase | |
| Receptors, CCR4 | |
| Tumor Microenvironment |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P30 CA023108 | NCI NIH HHS | United States | P30CA023108 | PubMed and NIH | NIH RePORTER |
| R01 CA120777 | NCI NIH HHS | United States | R01CA120777 | PubMed and NIH | NIH RePORTER |
| R01 CA214062 | NCI NIH HHS | United States | R01CA214062 | PubMed and NIH | NIH RePORTER |
| R21 CA209375 | NCI NIH HHS | United States | R21CA209375 | PubMed and NIH | NIH RePORTER |
| R01 CA205965 | NCI NIH HHS | United States | R01CA205965 | PubMed and NIH | NIH RePORTER |
| T32 AI007363 | NIAID NIH HHS | United States | T32AI007363 | PubMed | NIH RePORTER |
| R01 CA225028 | NCI NIH HHS | United States | R01CA225028 | PubMed and NIH | NIH RePORTER |
| P30 GM103415 | NIGMS NIH HHS | United States | P30GM103415 | PubMed and NIH | NIH RePORTER |
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17000676 | Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/17000676 | PubMed |
| 2 | 17001349 | Oncogenic BRAF regulates beta-Trcp expression and NF-kappaB activity in human melanoma cells. | Oncogene | 2007 | https://conductscience.org/library/papers/17001349 | PubMed |
| 3 | 21873989 | Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. | Nat Med | 2011 | https://conductscience.org/library/papers/21873989 | PubMed |
| 4 | 16079850 | BRAFE600-associated senescence-like cell cycle arrest of human naevi. | Nature | 2005 | https://conductscience.org/library/papers/16079850 | PubMed |
| 5 | 17615234 | Association of cervical cancer with the presence of CD4+ regulatory T cells specific for human papillomavirus antigens. | Proc Natl Acad Sci U S A | 2007 | https://conductscience.org/library/papers/17615234 | PubMed |
| 6 | 17596146 | Evaluation of tumour-infiltrating CD4+CD25+FOXP3+ regulatory T cells in human cutaneous benign and atypical naevi, melanomas and melanoma metastases. | Br J Dermatol | 2007 | https://conductscience.org/library/papers/17596146 | PubMed |
| 7 | 27642636 | Lack of immunoediting in murine pancreatic cancer reversed with neoantigen. | JCI Insight | 2016 | https://conductscience.org/library/papers/27642636 | PubMed |
| 8 | 23471412 | Aire-dependent thymic development of tumor-associated regulatory T cells. | Science | 2013 | https://conductscience.org/library/papers/23471412 | PubMed |
| 9 | 23640603 | Ex vivo analysis of pancreatic cancer-infiltrating T lymphocytes reveals that ENO-specific Tregs accumulate in tumor tissue and inhibit Th1/Th17 effector cell functions. | Cancer Immunol Immunother | 2013 | https://conductscience.org/library/papers/23640603 | PubMed |
| 10 | 25790431 | Transcriptional regulation of chemokine expression in ovarian cancer. | Biomolecules | 2015 | https://conductscience.org/library/papers/25790431 | PubMed |
| 11 | 27521269 | Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis. | Immunity | 2016 | https://conductscience.org/library/papers/27521269 | PubMed |
| 12 | 16618776 | Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. | Cancer Res | 2006 | https://conductscience.org/library/papers/16618776 | PubMed |
| 13 | 23986400 | Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells. | Sci Transl Med | 2013 | https://conductscience.org/library/papers/23986400 | PubMed |
| 14 | 25970248 | Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity. | Nature | 2015 | https://conductscience.org/library/papers/25970248 | PubMed |
| 15 | 25183499 | BRAF inhibition alleviates immune suppression in murine autochthonous melanoma. | Cancer Immunol Res | 2014 | https://conductscience.org/library/papers/25183499 | PubMed |
| 16 | 21156649 | Analysis of the T-cell receptor repertoires of tumor-infiltrating conventional and regulatory T cells reveals no evidence for conversion in carcinogen-induced tumors. | Cancer Res | 2011 | https://conductscience.org/library/papers/21156649 | PubMed |
| 17 | 17616708 | Induction of postsurgical tumor immunity and T-cell memory by a poorly immunogenic tumor. | Cancer Res | 2007 | https://conductscience.org/library/papers/17616708 | PubMed |
| 18 | 17312132 | Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta. | J Immunol | 2007 | https://conductscience.org/library/papers/17312132 | PubMed |
| 19 | 23454771 | Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. | J Clin Invest | 2013 | https://conductscience.org/library/papers/23454771 | PubMed |
| 20 | 14738769 | Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. | Immunity | 2004 | https://conductscience.org/library/papers/14738769 | PubMed |
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42920839 | Regulatory T cell heterogeneity: who they are, where they come from, and where they go. | Front Immunol | 2026 | https://conductscience.org/library/papers/42920839 | PubMed |
| 42906944 | Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42906944 | PubMed |
| 42769030 | Spatial Treg niches and the therapeutic reprogramming of tumour tolerance in cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42769030 | PubMed |
| 42552305 | Migration of immune cells in tumors and inflammation: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42552305 | PubMed |
| 42523496 | The initial melanoma T cell infiltrate is defined by tissue-resident programs restrained by regulatory T cells. | Res Sq | 2026 | https://conductscience.org/library/papers/42523496 | PubMed |
| 42212208 | Phenotypic alterations in the immune system and tolerance induction in tumor-draining lymph nodes. | Iran J Basic Med Sci | 2026 | https://conductscience.org/library/papers/42212208 | PubMed |
| 42098518 | Homeobox A10 in gastrointestinal malignancies: unraveling metastatic mechanisms and novel therapeutic opportunities. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42098518 | PubMed |
| 41868670 | BRAF mutation and tumor immune microenvironment in new era. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/41868670 | PubMed |
| 41851514 | Mucosal melanoma of the head and neck region: clinical-pathologic implications of tumor microenvironment evaluated with multiplex immunohistochemistry. | Virchows Arch | 2026 | https://conductscience.org/library/papers/41851514 | PubMed |
| 41813655 | Chemokine-chemokine receptor axis: Emerging immunotherapeutic paradigms for solid tumor microenvironment reprogramming. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/41813655 | PubMed |
| 41575516 | Integrated approaches to sensitizing melanoma to radiotherapy. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/41575516 | PubMed |
| 41482575 | The immunology of vitiligo. | Nat Rev Immunol | 2026 | https://conductscience.org/library/papers/41482575 | PubMed |
| 41446197 | Cellular interactions in the sentinel lymph node predict melanoma recurrence. | bioRxiv | 2025 | https://conductscience.org/library/papers/41446197 | PubMed |
| 41279375 | Regulatory T cells inhibit CD8+ TRM-like cells during the early stages of tumor immune escape. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279375 | PubMed |
| 41258633 | Relationship between the BRAF-V600E variant allele frequency and clinicopathological characteristics of papillary thyroid carcinoma and its clinical application. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41258633 | PubMed |
| 41225509 | Vemurafenib, cetuximab and camrelizumab in BRAF V600E-mutated/MSS metastatic colorectal cancer. | J Transl Med | 2025 | https://conductscience.org/library/papers/41225509 | PubMed |
| 41087343 | Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/41087343 | PubMed |
| 40866864 | Baseline tumor burden predicts the efficacy of first-line chemoimmunotherapy in patients with advanced non-small cell lung cancer: results from 2 phase 3 randomized placebo-controlled trials. | BMC Cancer | 2025 | https://conductscience.org/library/papers/40866864 | PubMed |
| 40831885 | Autologous Tumor-Infiltrating Lymphocyte Infusion plus Anti-Programmed Cell Death Protein 1 Therapy to Cure Advanced Hepatocellular Carcinoma following Palliative Hepatectomy. | Liver Cancer | 2025 | https://conductscience.org/library/papers/40831885 | PubMed |
| 40749665 | Mutations in MLL3 promote breast cancer progression via HIF1α-dependent intratumoral recruitment and differentiation of regulatory T cells. | Immunity | 2025 | https://conductscience.org/library/papers/40749665 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| CCR4 | 1233 | PubTator's text mining | https://conductscience.org/library/genes/1233 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 | NCBI Gene |
| PMEL | 6490 | PubTator's text mining | https://conductscience.org/library/genes/6490 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30026331
GET https://conductscience.org/api/papers/v1/30026331/references?page=2